Zimmer Biomet stock holds steady ahead of late-September ex-dividend date

Zimmer Biomet Holdings, Inc. stock (ISIN US98956P1021) closed at USD 95.36 on the New York Stock Exchange on September 18, 2026, leaving the medical device group roughly 10.8 percent below its 52-week high of USD 106.88 and 20.5 percent above the 52-week low of USD 79.12 as investors position for a late-September ex-dividend date.

Dividend update sets near-term catalyst

According to StockAnalysis as of September 18, 2026, Zimmer Biomet has an annual dividend of USD 0.96 per share, paid in four quarterly installments and corresponding to a forward dividend yield of about 1.01 percent at recent price levels.

The same dividend overview from StockAnalysis highlights a cash dividend of USD 0.24 per share scheduled with an ex-dividend date on September 30, 2026 and a pay date on October 30, 2026, providing a concrete income event that many income-oriented investors use as a reference point.

Share price and market metrics in late September 2026

Price snapshots compiled by Reuters show Zimmer Biomet shares most recently quoted around USD 95.36, with a daily gain of 1.18 percent versus the prior close on September 18, 2026 and an intraday trading range between approximately USD 93.71 and USD 96.16 on that date.

Market capitalization data reported by a Nasdaq-based equity portal and summarized in a recent overview put Zimmer Biomet’s equity value at about USD 18.18 billion as of September 18, 2026, a level that broadly reflects the underlying share price movement over the year and places the company mid-sized within the global medical devices sector.

Income profile and risk considerations for investors

With a 52-week high of USD 106.88 and a low of USD 79.12, the current price region around USD 95.36 leaves Zimmer Biomet stock trading closer to the upper end of its range yet still offering approximately 10.8 percent distance to the recent high, a balance between some potential for price recovery and the risk that the shares remain range-bound.

The forward annual dividend of USD 0.96 per share, broken into four quarterly payments of USD 0.24 each, translates into a yield of roughly 1.01 percent at the September 18, 2026 closing price according to StockAnalysis, so the stock’s income component is modest compared with high-yield sectors but can still contribute to total return.

For investors, the timing of the USD 0.24 per share ex-dividend on September 30, 2026 and the pay date on October 30, 2026 is a practical checkpoint: it focuses attention on whether Zimmer Biomet’s fundamental performance in 2026 and beyond can support both continued dividend payments at this level and any potential growth in the payout over time.

Zimmer Biomet stock price context

Zimmer Biomet stock closed at USD 95.36 on the New York Stock Exchange on September 18, 2026, with that closing price as the current reference level for investors assessing the medical device group’s valuation.

More news and analyses on Zimmer Biomet stock